Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Oct;166(4):708-711.
doi: 10.1016/j.chest.2024.04.038. Epub 2024 Jun 10.

Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study

Benjamin Gaborit  1 , Romain Lécuyer  2 , Nahéma Issa  3 , Fabrice Camou  3 , Rose-Anne Lavergne  4 , Frederic Gabriel  5 , Florent Morio  4 , Emmanuel Canet  6 , François Raffi  7 , David Boutoille  8 , Anne Cady  9 , Marie Gousseff  9 , Yoann Crabol  9 , Antoine Néel  10 , Benoît Tessoulin  11 ; Prognostic Factors in Pneumocystis Pneumoniae (PRONOCYSTIS) Study Group
Collaborators, Affiliations
Free article
Multicenter Study

Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study

Benjamin Gaborit et al. Chest. 2024 Oct.
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: B. G. reports receipt of nonfinancial support from Gilead Sciences, MSD, and Pfizer outside the submitted work. F. R. reports receipt of personal fees from AbbVie, AstraZeneca, Gilead Sciences, Janssen, Merck, Roche, and ViiV Healthcare outside the submitted work. E. C. reports personal fees from GILEAD, SANOFI-GENZYME, and BAXTER outside the submitted work. B. T. reports receipt of nonfinancial support from Gilead Sciences and personal fees from AbbVie, Gilead Sciences, Lilly Oncology, and Incyte outside the submitted work. None declared (R. Lécuyer, N. I., F. C., R. Lavergne, F. G., F. M., D. B., A. C., M. G., Y. C., A. N.).

Publication types

LinkOut - more resources